Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · September 14, 2022

Angiotensin Receptor Blockers and Beta Blockers in Marfan Syndrome

The Lancet


Additional Info

The Lancet
Angiotensin receptor blockers and β blockers in Marfan syndrome: an individual patient data meta-analysis of randomised trials
Lancet 2022 Sep 10;400(10355)822-831, A Pitcher, E Spata, J Emberson, K Davies, H Halls, L Holland, K Wilson, C Reith, AH Child, T Clayton, M Dodd, M Flather, XY Jin, G Sandor, M Groenink, B Mulder, J De Backer, A Evangelista, A Forteza, G Teixido-Turà, C Boileau, G Jondeau, O Milleron, RV Lacro, LA Sleeper, HH Chiu, MH Wu, S Neubauer, H Watkins, H Dietz, C Baigent

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading